2 Patients should be at least four weeks from the last day of therapeutic radiation or cytotoxic chemotherapy or from antibody therapy or at least five half-lives from non-cytotoxic targeted or biologic therapy Patients may have received palliative radiation immediately before or during treatment provided radiation is not to the only target lesion available 